These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2360465)

  • 41. Cotreatment with a novel phosphoinositide analogue inhibitor and carmustine enhances chemotherapeutic efficacy by attenuating AKT activity in gliomas.
    Van Meter TE; Broaddus WC; Cash D; Fillmore H
    Cancer; 2006 Nov; 107(10):2446-54. PubMed ID: 17041888
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rationale for preirradiation chemotherapy in treatment of malignant gliomas.
    Beck DO; Hochberg FH
    J Neurosurg; 1985 Dec; 63(6):994-6. PubMed ID: 4056918
    [No Abstract]   [Full Text] [Related]  

  • 43. In vitro analysis of BCNU-sensitivity in human malignant gliomas. II. Cross-resistance studies with cisplatinum and nitrosoureas.
    Gerosa MA; Rosenblum ML; Stevanoni G; Licata C; Della Corte V; Marcon C; Bricolo A; Tridente G
    Acta Neurol Scand; 1986 Jan; 73(1):66-70. PubMed ID: 3006422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.
    Levin VA; Silver P; Hannigan J; Wara WM; Gutin PH; Davis RL; Wilson CB
    Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):321-4. PubMed ID: 2154418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Value of combined chemotherapy in "relatively benign gliomas"].
    Constantinovici A; Cristescu A; Budulan G
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1987; 32(1):25-33. PubMed ID: 2955497
    [No Abstract]   [Full Text] [Related]  

  • 47. Phase I-II diaziquone chemotherapy in brain tumors.
    Madajewicz S; Spaulding M; Bhimani S; Avellanosa A; DeLos Santos R; Perry A; Zeigler P; Kirshner J
    Cancer Treat Rep; 1984 Jun; 68(6):913-4. PubMed ID: 6733706
    [No Abstract]   [Full Text] [Related]  

  • 48. Quantitative DNA analysis of an intracerebrally transplanted brain tumour model after experimental chemotherapy with BCNU and CCNU.
    Schlegel J; Stumm G; Ruschoff J; Mennel HD
    Exp Toxicol Pathol; 1995 Sep; 47(4):313-8. PubMed ID: 8855128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Limitations of high dose intra-arterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) chemotherapy for malignant gliomas.
    Kapp J; Vance R; Parker JL; Smith RR
    Neurosurgery; 1982 Jun; 10(6 Pt 1):715-9. PubMed ID: 7110545
    [No Abstract]   [Full Text] [Related]  

  • 50. Intracarotid infusion of ACNU and BCNU as adjuvant therapy of malignant gliomas. Clinical aspects and critical considerations.
    Papavero L; Loew F; Jaksche H
    Acta Neurochir (Wien); 1987; 85(3-4):128-37. PubMed ID: 3035882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
    Slagel DE; Feola J; Houchens DP; Ovejera AA
    Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
    Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
    Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The 9L rat brain tumor model for pre-clinical investigation of radiation-chemotherapy interactions.
    Kimler BF
    J Neurooncol; 1994; 20(2):103-9. PubMed ID: 7528789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delayed response to brain tumor chemotherapy.
    Seiler RW
    Surg Neurol; 1979 Feb; 11(2):97-100. PubMed ID: 424990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy of brain tumors.
    Galanis E; Buckner JC
    Curr Opin Neurol; 2000 Dec; 13(6):619-25. PubMed ID: 11148660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nitrosoureas in central nervous system tumors.
    Walker MD
    Cancer Chemother Rep 3; 1973 May; 4(3):21-6. PubMed ID: 4584033
    [No Abstract]   [Full Text] [Related]  

  • 57. Reirradiation and lomustine in patients with relapsed high-grade gliomas.
    Arcicasa M; Roncadin M; Bidoli E; Dedkov A; Gigante M; Trovò MG
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):789-93. PubMed ID: 10098434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective delivery of chemotherapeutic agents with a new catheter system.
    Wolpert SM; Kwan ES; Heros D; Kasdon DL; Hedges TR
    Radiology; 1988 Feb; 166(2):547-9. PubMed ID: 3336733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low-grade gliomas.
    Schiff D
    Continuum (Minneap Minn); 2015 Apr; 21(2 Neuro-oncology):345-54. PubMed ID: 25837900
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer Council.
    Haid M; Khandekar JD; Christ M; Johnson CM; Miller SJ; Locker GY; Merrill JM; Reisel H; Hatfield A; Lanzotti V
    Cancer; 1985 Sep; 56(6):1311-5. PubMed ID: 4027870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.